BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33544518)

  • 1. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis.
    Campello E; Bulato C; Spiezia L; Boscolo A; Poletto F; Cola M; Gavasso S; Simion C; Radu CM; Cattelan A; Tiberio I; Vettor R; Navalesi P; Simioni P
    Clin Chem Lab Med; 2021 Jun; 59(7):1323-1330. PubMed ID: 33544518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
    Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
    Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients.
    de la Morena-Barrio ME; Bravo-Pérez C; Miñano A; de la Morena-Barrio B; Fernandez-Perez MP; Bernal E; Gómez-Verdu JM; Herranz MT; Vicente V; Corral J; Lozano ML
    Sci Rep; 2021 Apr; 11(1):7792. PubMed ID: 33833254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort.
    van de Berg TW; Mulder MMG; Alnima T; Nagy M; van Oerle R; Beckers EAM; Hackeng TM; Hulshof AM; Sels JEM; Henskens YMC; van der Horst ICC; Ten Cate H; Spronk HMH; van Bussel BCT;
    Front Cardiovasc Med; 2022; 9():929284. PubMed ID: 36277784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma.
    Velasco-Rodríguez D; Martínez-Alfonzo I; Velasco-Valdazo AE; Revilla N; Mahíllo-Fernández I; Askari E; Castro-Quismondo N; Laso RV; Domingo-González A; Serrano-López J; Prieto E; Rosado B; Blanchard MJ; Martín-Herrero S; García-Raso A; Bueno MÁ; de la Plaza R; Peñaherrera M; López IG; López-Jiménez J; Martínez-López J; Llamas-Sillero P
    J Thromb Thrombolysis; 2023 Apr; 55(3):464-473. PubMed ID: 36630029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.
    Kelliher S; Weiss L; Cullivan S; O'Rourke E; Murphy CA; Toolan S; Lennon Á; Szklanna PB; Comer SP; Macleod H; Le Chevillier A; Gaine S; O'Reilly KMA; McCullagh B; Stack J; Maguire PB; Ní Áinle F; Kevane B
    J Thromb Haemost; 2022 Apr; 20(4):1008-1014. PubMed ID: 35102689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients.
    Cohen O; Landau N; Avisahai E; Brutman-Barazani T; Budnik I; Livnat T; Asraf K; Doolman R; Levy-Mendelovich S; Efros O; Manor U; Meltzer E; Segal G; Rahav G; Kenet G
    Acta Haematol; 2023; 146(2):151-160. PubMed ID: 36273451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
    Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
    Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19.
    Mennuni MG; Rolla R; Grisafi L; Spinoni EG; Rognoni A; Lio V; Castello LM; Sainaghi PP; Pirisi M; Avanzi GC; Krengli M; Bellan M; Ferrante D; Aimaretti G; Dianzani U; Patti G
    J Thromb Thrombolysis; 2021 Oct; 52(3):746-753. PubMed ID: 34110529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation in subjects with lupus anticoagulant without prior thrombosis or gestational morbidities.
    Velasco-Rodríguez D; Laso RV; García-Raso A; Mahíllo-Fernández I; Guzmán-López K; Martín-Herrero S; Barral EJ; Vegas-Sánchez MDC; Martínez-Becerra MJ; de la Plaza R; Romero LFL; Mínguez D; Alonso-Domínguez JM; López CB; López AG; Fernández MSS; Llamas-Sillero P
    Thromb Res; 2020 Dec; 196():425-431. PubMed ID: 33038586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of thrombomodulin-modified thrombin generation in uncomplicated pregnancy: the normal range and prothrombotic phenotype.
    Dong F; Lv Z; Di P
    Scand J Clin Lab Invest; 2023 Apr; 83(2):79-85. PubMed ID: 36688605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability.
    van de Berg TW; Hulshof AM; Nagy M; van Oerle R; Sels JW; van Bussel B; Ten Cate H; Henskens Y; Spronk HMH;
    Thromb Res; 2021 May; 201():84-89. PubMed ID: 33662799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.
    Vagrecha A; Stanco J; Majeed S; Kouides P; Acharya SS
    Haemophilia; 2021 Jul; 27(4):e517-e519. PubMed ID: 33427345
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
    Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
    Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT.
    Vahtera A; Szanto T; Lassila R; Valkonen M; Sivula M; Huhtala H; Pettilä V; Kuitunen A
    Acta Anaesthesiol Scand; 2021 Jan; 65(1):109-115. PubMed ID: 32888192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.
    Chaireti R; Rajani R; Bergquist A; Melin T; Friis-Liby IL; Kapraali M; Kechagias S; Lindahl TL; Almer S
    Thromb Res; 2014 Aug; 134(2):455-61. PubMed ID: 24913997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis.
    Senzolo M; Rodriguez-Castro KI; Rossetto V; Radu C; Gavasso S; Carraro P; Zerbinati P; Sartori MT; Simioni P
    J Thromb Haemost; 2012 Sep; 10(9):1823-9. PubMed ID: 22712870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.
    Tripodi A; Legnani C; Chantarangkul V; Cosmi B; Palareti G; Mannucci PM
    J Thromb Haemost; 2008 Aug; 6(8):1327-33. PubMed ID: 18485081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation Factor Levels and Underlying Thrombin Generation Patterns in Adult Extracorporeal Membrane Oxygenation Patients.
    Mazzeffi M; Strauss E; Meyer M; Hasan S; Judd M; Abuelkasem E; Chow J; Nandwani V; McCarthy P; Tanaka K
    Anesth Analg; 2019 Sep; 129(3):659-666. PubMed ID: 31425204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
    Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
    Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.